Approval · Notice of Compliance 9004 · 2007
LEVITRA: Notice of Compliance 9004
Issued August 30, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9004
- Date
- August 30, 2007
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Pde5 inhibitor, treatment of erectile dysfunction
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEVITRA | Not yet assigned | — |
Medicinal ingredients
- VARDENAFIL HYDROCHLORIDE 5 MG per TAB
- VARDENAFIL HYDROCHLORIDE 10 MG per TAB
- VARDENAFIL HYDROCHLORIDE 20 MG per TAB